Literature DB >> 27676132

Interactions of the Disordered Domain II of Hepatitis C Virus NS5A with Cyclophilin A, NS5B, and Viral RNA Show Extensive Overlap.

Marianne Ngure1,2, Moheshwarnath Issur2, Nikoloz Shkriabai3, Hsiao-Wei Liu2, Gonzalo Cosa4, Mamuka Kvaratskhelia3, Matthias Götte1,2,5.   

Abstract

Domain II of the nonstructural protein 5 (NS5A) of the hepatitis C virus (HCV) is involved in intermolecular interactions with the viral RNA genome, the RNA-dependent RNA polymerase NS5B, and the host factor cyclophilin A (CypA). However, domain II of NS5A (NS5ADII) is largely disordered, which makes it difficult to characterize the protein-protein or protein-nucleic acid interfaces. Here we utilized a mass spectrometry-based protein footprinting approach in attempts to characterize regions forming contacts between NS5ADII and its binding partners. In particular, we compared surface topologies of lysine and arginine residues in the context of free and bound NS5ADII. These experiments have led to the identification of an RNA binding motif (305RSRKFPR311) in an arginine-rich region of NS5ADII. Furthermore, we show that K308 is indispensable for both RNA and NS5B binding, whereas W316, further downstream, is essential for protein-protein interactions with CypA and NS5B. Most importantly, NS5ADII binding to NS5B involves a region associated with RNA binding within NS5B. This interaction down-regulated RNA synthesis by NS5B, suggesting that NS5ADII modulates the activity of NS5B and potentially regulates HCV replication.

Entities:  

Keywords:  CypA; HCV; NS5A domain II; NS5B; mass spectrometry

Mesh:

Substances:

Year:  2016        PMID: 27676132     DOI: 10.1021/acsinfecdis.6b00143

Source DB:  PubMed          Journal:  ACS Infect Dis        ISSN: 2373-8227            Impact factor:   5.084


  12 in total

1.  Adaptive Mutations in Replicase Transmembrane Subunits Can Counteract Inhibition of Equine Arteritis Virus RNA Synthesis by Cyclophilin Inhibitors.

Authors:  Eric J Snijder; Clara C Posthuma; Adriaan H de Wilde; A Linda Boomaars-van der Zanden; Anja W M de Jong; Montserrat Bárcena
Journal:  J Virol       Date:  2019-08-28       Impact factor: 5.103

2.  Cyclophilin A allows the allosteric regulation of a structural motif in the disordered domain 2 of NS5A and thereby fine-tunes HCV RNA replication.

Authors:  Marie Dujardin; Vanesa Madan; Neha S Gandhi; François-Xavier Cantrelle; Hélène Launay; Isabelle Huvent; Ralf Bartenschlager; Guy Lippens; Xavier Hanoulle
Journal:  J Biol Chem       Date:  2019-07-17       Impact factor: 5.157

Review 3.  Hepatitis C Virus Replication.

Authors:  Keisuke Tabata; Christopher J Neufeldt; Ralf Bartenschlager
Journal:  Cold Spring Harb Perspect Med       Date:  2020-03-02       Impact factor: 6.915

4.  ISGylation of Hepatitis C Virus NS5A Protein Promotes Viral RNA Replication via Recruitment of Cyclophilin A.

Authors:  Takayuki Abe; Nanae Minami; Rheza Gandi Bawono; Chieko Matsui; Lin Deng; Takasuke Fukuhara; Yoshiharu Matsuura; Ikuo Shoji
Journal:  J Virol       Date:  2020-09-29       Impact factor: 5.103

5.  A role for domain I of the hepatitis C virus NS5A protein in virus assembly.

Authors:  Chunhong Yin; Niluka Goonawardane; Hazel Stewart; Mark Harris
Journal:  PLoS Pathog       Date:  2018-01-19       Impact factor: 6.823

Review 6.  Cyclophilin A: a key player for etiological agent infection.

Authors:  Yating Liao; Dan Luo; Kailan Peng; Yanhua Zeng
Journal:  Appl Microbiol Biotechnol       Date:  2021-01-25       Impact factor: 5.560

7.  Interaction study between HCV NS5A-D2 and NS5B using 19F NMR.

Authors:  Marie Dujardin; François-Xavier Cantrelle; Guy Lippens; Xavier Hanoulle
Journal:  J Biomol NMR       Date:  2017-12-07       Impact factor: 2.835

8.  NMR reveals the intrinsically disordered domain 2 of NS5A protein as an allosteric regulator of the hepatitis C virus RNA polymerase NS5B.

Authors:  Luiza M Bessa; Hélène Launay; Marie Dujardin; François-Xavier Cantrelle; Guy Lippens; Isabelle Landrieu; Robert Schneider; Xavier Hanoulle
Journal:  J Biol Chem       Date:  2017-09-14       Impact factor: 5.486

Review 9.  Cyclophilins and cyclophilin inhibitors in nidovirus replication.

Authors:  Adriaan H de Wilde; Uyen Pham; Clara C Posthuma; Eric J Snijder
Journal:  Virology       Date:  2018-07-12       Impact factor: 3.616

10.  Hepatitis C virus exploits cyclophilin A to evade PKR.

Authors:  Che C Colpitts; Sophie Ridewood; Bethany Schneiderman; Justin Warne; Keisuke Tabata; Caitlin F Ng; Ralf Bartenschlager; David L Selwood; Greg J Towers
Journal:  Elife       Date:  2020-06-16       Impact factor: 8.140

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.